Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CYCN
CYCN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CYCN News
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
Apr 09 2026
PRnewswire
Investigation Alerts for Multiple Company Mergers
Apr 09 2026
Globenewswire
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
Apr 07 2026
Globenewswire
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
Apr 03 2026
Globenewswire
Investigation Launched into Cyclerion's Transaction with Korsana
Apr 01 2026
PRnewswire
U.S. March Manufacturing PMI Slightly Rises
Apr 01 2026
seekingalpha
Cyclerion Announces All-Stock Merger with Korsana Biosciences
Apr 01 2026
NASDAQ.COM
Cyclerion Therapeutics Announces Merger with Korsana Biosciences, Shares Surge
Apr 01 2026
stocktwits
Korsana Biosciences and Cyclerion Merge to Advance Alzheimer's Treatment
Apr 01 2026
Newsfilter
Cyclerion Receives Positive FDA Feedback, Advancing CYC-126 Study
Feb 17 2026
Newsfilter
AZZ Inc Reports Q3 Earnings Beat, Shares Rise 2.1%
Jan 08 2026
Benzinga
Alumis Inc. Shares Surge 132% After Successful Phase 3 Trial Results
Jan 06 2026
Benzinga
AngioDynamics Surpasses Expectations with $79.4M Sales and Break-Even EPS
Jan 06 2026
Benzinga
Cyclerion (CYCN) Enters Exclusive Collaboration with Medsteer to Advance CYC-126 Clinical Trials
Jan 06 2026
NASDAQ.COM
Cyclerion Therapeutics Expands Collaboration with Medsteer, Shares Surge 44.2%
Jan 06 2026
Benzinga
Cycurion Secures Over $1 Million Contract to Upgrade Federal Emergency Warning System
Nov 10 2025
Benzinga
Show More News
